DOCT — Beyond Medical Technologies Cashflow Statement
0.000.00%
Last trade - 00:00- CA$19.17m
- CA$18.98m
- 14
- 18
- 72
- 26
Annual cashflow statement for Beyond Medical Technologies, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2020 December 31st | C2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -6.52 | -2.91 | -1.4 | -0.552 | -0.366 |
| Depreciation | |||||
| Non-Cash Items | 4.46 | 1.38 | 0.414 | -0.026 | -0.072 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.084 | 0.132 | 0.093 | 0.076 | 0.357 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Payable / Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -1.83 | -1.4 | -0.894 | -0.503 | -0.081 |
| Capital Expenditures | -0.234 | — | — | — | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -0.026 | -0.468 | 0 | — | — |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.26 | -0.468 | 0 | — | — |
| Financing Cash Flow Items | — | -0.08 | 0 | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -0.066 | 2.67 | 0 | 0.03 | 0.03 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -2.16 | 0.807 | -0.894 | -0.473 | -0.051 |